• Home
  • News
  • Analysis
  •  
    Regions
    • South Asia
    • North America
    • Europe
    • Central Asia
    • Australasia
    • MENA
    • Southeast Asia
    • Greater China
    • North Asia
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Credit
    • Early stage
    • PIPE
  •  
    Exits
    • Buyback
    • IPO
    • Open market
    • Trade sale
  •  
    Sectors
    • Real Estate
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • Greater China

Chinese medical device company Ankon raises $100m

  • Winnie Liu
  • 16 August 2017
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

Shanghai-based Ankon Medical Technologies, which develops medical equipment for gastric examination, has raised a $100 million round of funding from investors including SBCVC.

Domestic PE investors including Dazhong Investment, Pre-IPO Capital Partners, Qiansheng Investment, and Tongsheng Capital also invested. SBCVC previously invested in Ankon in February.

Ankon was founded in 2008. Its flagship product is Navicam, a capsule endoscopy device that helps collect image data of patients' digestive tract. After patients swallow the capsule, the camera inside takes pictures that are transmitted to a recorder worn on a belt. During the 15-minute examination procedure, the endoscopist can remotely control the capsule to improve visualization of the stomach and digestive system. The data is downloaded to a computer for analysis by a doctor.

Navicam has obtained approvals from the China Food and Drug Administration. At present, nearly 1,000 Chinese medical institutions use Navicam for diagnosis of gastric diseases. With the latest funding, the company plans to expand overseas and develop more technology for early diagnosis of various diseases.

SBCVC is investing from its fifth fund, which closed at $459 million early last year. The firm targets technology, media and telecom (TMT), healthcare, cleantech and new materials sectors.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • Greater China
  • Healthcare
  • Early-stage
  • Technology
  • China
  • Softbank China Venture Capital
  • Venture

More on Greater China

Lower valuations, less leverage could drive China PE returns - HKMA Forum
Lower valuations, less leverage could drive China PE returns - HKMA Forum
  • Greater China
  • 09 November 2023
Ascendent bids $1.6b for China's Hollysys Automation
Ascendent bids $1.6b for China's Hollysys Automation
  • Greater China
  • 07 November 2023
Sinovation-developed LLM platform hits $1b valuation
Sinovation-developed LLM platform hits $1b valuation
  • Greater China
  • 06 November 2023
PE-backed Guoquan Food raises $52.5m in Hong Kong IPO
PE-backed Guoquan Food raises $52.5m in Hong Kong IPO
  • Greater China
  • 06 November 2023

Latest News

Asian GPs slow implementation of ESG policies - survey
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
Singapore fintech start-up LXA gets $10m seed round
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
India's InCred announces $60m round, claims unicorn status
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
Insight leads $50m round for Australia's Roller
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013